当前位置:首页 - 行情中心 - 南模生物(688265) - 财务分析 - 现金流量表

南模生物

(688265)

  

流通市值:45.06亿  总市值:45.06亿
流通股本:7796.35万   总股本:7796.35万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金166,615,684.1466,344,553.51379,544,474.49243,930,743.32
  收到的税费返还--3,653,434.592,805,667.31
  收到其他与经营活动有关的现金7,040,017.741,720,549.4920,635,284.064,078,481.85
  经营活动现金流入小计173,655,701.8868,065,103403,833,193.14250,814,892.48
  购买商品、接受劳务支付的现金44,881,767.9224,776,535.6293,241,115.1371,518,213.13
  支付给职工以及为职工支付的现金96,730,926.4252,021,158.83165,469,638.48136,133,446.55
  支付的各项税费1,997,337.421,392,607.669,290,764.156,215,713.71
  支付其他与经营活动有关的现金26,373,066.5416,621,294.2464,267,655.943,530,295.83
  经营活动现金流出小计169,983,098.394,811,596.35332,269,173.66257,397,669.22
  经营活动产生的现金流量净额3,672,603.58-26,746,493.3571,564,019.48-6,582,776.74
二、投资活动产生的现金流量:
  收回投资收到的现金1,511,920,549.41691,772,149.162,488,745,298.681,663,733,736.39
  取得投资收益收到的现金45,827.72104,414.02--
  处置固定资产、无形资产和其他长期资产收回的现金净额1,951.33-137,027.953,928.1
  投资活动现金流入小计1,511,968,328.46691,876,563.182,488,882,326.581,663,787,664.49
  购建固定资产、无形资产和其他长期资产支付的现金7,553,546.993,871,150.3325,237,036.0220,452,994.83
  投资支付的现金1,517,000,000777,000,0002,354,010,0001,589,000,000
  投资活动现金流出小计1,524,553,546.99780,871,150.332,379,247,036.021,609,452,994.83
  投资活动产生的现金流量净额-12,585,218.53-88,994,587.15109,635,290.5654,334,669.66
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金--10,004,068.8910,004,068.89
  支付其他与筹资活动有关的现金8,796,267.423,702,170.5673,098,791.3367,736,946.62
  筹资活动现金流出小计8,796,267.423,702,170.5683,102,860.2277,741,015.51
  筹资活动产生的现金流量净额-8,796,267.42-3,702,170.56-83,102,860.22-77,741,015.51
四、汇率变动对现金及现金等价物的影响-225,891.22-62,777.96515,474.38544,476.12
  现金及现金等价物净增加额平衡项目-0.01000
五、现金及现金等价物净增加额-17,934,773.6-119,506,029.0298,611,924.2-29,444,646.47
  加:期初现金及现金等价物余额196,214,845.6196,214,845.697,602,921.497,602,921.4
  期末现金及现金等价物余额178,280,07276,708,816.58196,214,845.668,158,274.93
补充资料:
  净利润18,167,375-6,495,504.05-
  资产减值准备1,712,063.32-844,076.86-
  固定资产和投资性房地产折旧15,143,675.14-29,685,141.95-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,143,675.14-29,685,141.95-
  无形资产摊销3,726,238.9-6,801,627.64-
  长期待摊费用摊销8,972,725.81-17,962,341.57-
  处置固定资产、无形资产和其他长期资产的损失---20,207.24-
  固定资产报废损失44,107.19-55,081.16-
  公允价值变动损失-8,610,993.1--19,301,458.69-
  财务费用1,566,515.03-3,626,896.54-
  投资损失-1,181,013.5--1,041,919.05-
  递延所得税-589,887.75--3,759,022.98-
  其中:递延所得税资产减少-187,544.54--4,835,970.62-
    递延所得税负债增加-402,343.21-1,076,947.64-
  存货的减少-4,462,148.24-2,314,280.98-
  经营性应收项目的减少-22,590,807.28--8,364,848.45-
  经营性应付项目的增加-17,727,776.83-6,048,267.53-
  其他-8,111,810.24-2,361,382.9-
  现金的期末余额178,280,072-196,214,845.6-
  减:现金的期初余额196,214,845.6-97,602,921.4-
  现金及现金等价物的净增加额-17,934,773.6-98,611,924.2-
公告日期2025-08-292025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑